Looking Into Allarity Therapeutics's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Allarity Therapeutics (NYSE:ALLR) has seen a significant increase in short interest, with 40.86% of its float sold short, a 5654.93% rise since the last report. This high short interest compared to its peers could indicate bearish sentiment, but it may also present a bullish opportunity if the stock price rises.
September 16, 2024 | 7:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Allarity Therapeutics has experienced a dramatic increase in short interest, now at 40.86% of its float. This suggests a bearish market sentiment, but also presents a potential for a short squeeze if the stock price rises.
The significant rise in short interest indicates that investors are increasingly betting against Allarity Therapeutics, which could lead to downward pressure on the stock price. However, if the stock price rises, it could trigger a short squeeze, causing a rapid price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100